Active	Status	Sponsor type	Region	Phase	Filter
6 Active 1 Inactive 7 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fu, Ying
NCT04629872: Fingolimod in Endovascular Treatment of Ischemic Stroke	Recruiting	2	30	RoW	Fingolimod	Ning Wang, MD., PhD.	Stroke Inflammation	12/22	12/23
NCT04004819: Rituximab for HTLV-1-associated Myelopathy	Recruiting	2	100	RoW	Rituximab	First Affiliated Hospital of Fujian Medical University	HTLV-1-associated Myelopathy	07/23	07/24
NCT04101643: PCSK9 Inhibitor Treatment for Patients With SPG5	Recruiting	1/2	30	RoW	evolocumab	First Affiliated Hospital of Fujian Medical University	Hereditary Spastic Paraplegia Type 5	01/23	01/23
NCT05765487: Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%	Recruiting	1	15	Canada	Sildenafil, Vehicle, Placebo	Daré Bioscience, Inc., Strategic Science & Technologies, LLC	Sexual Arousal Disorder	04/24	07/24
NCT04171882: Microglial Cells Activation Imaging Using PET-CT With 18F-DPA714	Recruiting	N/A	500	RoW		Weibing Miao, PhD	Microglial Cells Activation Imaging	11/24	11/24
NCT04637074: A Cohort Study on Thrombectomy for Stroke	Recruiting	N/A	300	RoW		Ning Wang, MD., PhD.	Ischemic Stroke	12/25	12/25